Hydase (Akorn, Inc.)
Welcome to the PulseAid listing for the Hydase drug offered from Akorn, Inc.. This Endoglycosidase [EPC],Glycoside Hydrolases [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Akorn, Inc. |
| NON-PROPRIETARY NAME: | Hyaluronidase |
| SUBSTANCE NAME: | HYALURONIDASE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Endoglycosidase [EPC],Glycoside Hydrolases [Chemical/Ingredient] |
| ROUTE: | INFILTRATION; INTERSTITIAL; INTRAMUSCULAR; INTRAOCULAR; RETROBULBAR; SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-11-05 |
| END MARKETING DATE: | 0000-00-00 |
Hydase HUMAN PRESCRIPTION DRUG Details:
| Item Description | Hydase from Akorn, Inc. |
| LABELER NAME: | Akorn, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 150([USP’U]/mL) |
| START MARKETING DATE: | 2015-11-05 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 17478-560_df0f9541-2fbe-4017-a2ea-e5c6f7a3819a |
| PRODUCT NDC: | 17478-560 |
| APPLICATION NUMBER: | NDA021716 |
Other HYALURONIDASE Pharmaceutical Manufacturers / Labelers:
